MedTrace Logo

Human Comedogenicity Test

NCT03428997 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2023-07-03

Study results available
· View outcomes & findings →

Summary

Testing comedogenicity potential of a device cream on humans.

Conditions

  • Comedogenicity

Interventions

DEVICE

Lotion

Formulated Lotion F# 13451-131 was applied on an occlusive patch and placed on a test site on each subjects back three times a week for four weeks.

OTHER

Negative Control

Control. An undosed occlusive patch was placed on a test site on each subjects back three times a week for four weeks.

Sponsors & Collaborators

  • Johnson & Johnson Consumer Inc. (J&JCI)

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-20
Primary Completion
2018-02-05
Completion
2018-02-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03428997 on ClinicalTrials.gov